| Literature DB >> 34216538 |
Yanhui Li1, Yanhui Dong1, Zhiyong Zou1, Di Gao1, Xijie Wang1, Zhaogeng Yang1, Bin Dong1, Jun Ma1.
Abstract
Blood pressure (BP) increased with age and height development, but little was known about the effect of pubertal development on blood pressure in children. A cross-sectional study was performed among 4146 children aged 7-12 years old in China. Pubertal development was assessed based on breast stages and testicular volume. The associations of pubertal development with BP levels and the rate of elevated blood pressure (EBP) were quantified using multiple linear and logistic regressions. We found that pubertal developmental level was positively correlated with BP, and children who experienced puberty onset and early pubertal timing had higher BP levels and prevalence of EBP. After adjusting for covariates, children experienced puberty onset had 3.84 and 2.24 mmHg increase in systolic blood pressure and diastolic blood pressure, and 70%, 53%, and 62% increased odds of EBP, ESBP, and EDBP, respectively, compared with those without puberty onset. Similar results were observed for children who had early pubertal timing. The change of BP in puberty is greater and the association between pubertal development and BP is stronger in girls than boys. These findings suggested that pubertal development could be an important independent factor and one critical period for the EBP progress. Monitoring and management of pubertal development are necessary particularly among girls.Entities:
Keywords: blood pressure; children and adolescents; hypertension; pubertal development; pubertal timing
Mesh:
Year: 2021 PMID: 34216538 PMCID: PMC8678653 DOI: 10.1111/jch.14315
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738
FIGURE 1The selection process of participants
General characteristics of study participants
| Pubertal stage | |||||||
|---|---|---|---|---|---|---|---|
| Characteristics | Total | I | II | III | IV‐V |
|
|
| Number | 4146 | 2300 | 863 | 594 | 389 | ||
| Age (year) | 10.1 ± 1.5 | 9.2 ± 1.1 | 10.6 ± 1.2 | 11.5 ± 0.9 | 11.8 ± 0.7 | 1345.94 | <.01 |
| Girls (%) | 1755(42.3%) | 609(26.5%) | 477(55.3%) | 360(60.6%) | 309(79.4%) | 596.62 | <.01 |
| Height (cm) | 142.9 ± 11.1 | 136.6 ± 8.0 | 145.9 ± 8.6 | 153.7 ± 7.6 | 157.3 ± 6.8 | 1304.08 | <.01 |
| Weight (kg) | 36.4 ± 10.8 | 31.7 ± 8.5 | 38.3 ± 9.8 | 43.4 ± 9.8 | 48.8 ± 9.1 | 580.49 | <.01 |
| BMI (kg/m2) | 17.5 ± 3.3 | 16.8 ± 3.1 | 17.8 ± 3.3 | 18.3 ± 3.1 | 19.6 ± 3.1 | 118.27 | <.01 |
| SBP (mmHg) | 105.7 ± 11.5 | 102.5 ± 10.8 | 107.1 ± 10.7 | 110.8 ± 10.8 | 113.6 ± 10.8 | 187.55 | <.01 |
| DBP (mmHg) | 63.5 ± 9.4 | 61.8 ± 9.0 | 64.6 ± 9.0 | 65.6 ± 10.2 | 67.4 ± 9.3 | 63.65 | <.01 |
| ESBP (%) | 773(18.6%) | 343(14.9%) | 166(19.2%) | 142(23.9%) | 122(31.4%) | 73.63 | <.01 |
| EDBP (%) | 427(10.3%) | 184(8.0%) | 98(11.4%) | 85(14.3%) | 60(15.4%) | 35.61 | <.01 |
| EBP (%) | 933(22.5%) | 412(17.9%) | 208(24.1%) | 172(29.0%) | 141(36.2%) | 85.37 | <.01 |
| Family history of hypertension | 450(10.9%) | 239(10.4%) | 105(12.2%) | 61(10.3%) | 45(11.6%) | 2.46 | .48 |
| Taste preference | 54.00 | <.01 | |||||
| Partial salty | 812(20.1%) | 485(21.6%) | 171(20.3%) | 99(17.0%) | 57(15.0%) | ||
| Moderation | 2482(61.4%) | 1280(57.1%) | 535(63.4%) | 400(68.8%) | 267(70.4%) | ||
| Partial light | 509(12.6%) | 309(13.8%) | 98(11.6%) | 58(10.0%) | 44(11.6%) | ||
| Don't know | 242(6.0%) | 167(7.5%) | 40(4.7%) | 24(4.1%) | 11(2.9%) | ||
Continuous variables were expressed by mean values ± standard deviations, and categorical variables were expressed by numbers and percentages.
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; EBP, elevated blood pressure; EDBP, elevated diastolic blood pressure; ESBP, elevated systolic blood pressure; SBP, systolic blood pressure.
Indicated that the differences of characteristics were statistically significant compared with the pubertal stage I (p < .05).
The levels of BP at different pubertal developmental status in Chinese children aged 7–12 years
| Age | Group | N | SBP (mmHg) | Boys’ SBP (mmHg) | Girls’ SBP (mmHg) | DBP (mmHg) | Boys’ DBP (mmHg) | Girls’ DBP (mmHg) |
|---|---|---|---|---|---|---|---|---|
| 7 | Prepuberty | 318 | 100.40(99.22,101.58) | 102.61(101.01,104.22) | 97.52(95.89,99.14) | 60.37(59.35,61.39) | 61.22(59.83,62.61) | 59.26(57.78,60.75) |
| Puberty | 17 | 106.35(102.05,110.66) | – | 106.35(102.05,110.66) | 65.08(60.47,69.69) | – | 65.08(60.47,69.69) | |
| 8 | Prepuberty | 826 | 101.18(100.42,101.94) | 103.17(102.23,104.10) | 97.55(96.34,98.75) | 61.30(60.67,61.93) | 61.96(61.14,62.77) | 60.10(59.16,61.04) |
| Puberty | 94 | 106.98(104.71,109.24) | 110.29(99.82,120.76) | 106.67(104.32,109.02) | 65.57(63.36,67.78) | 67.21(57.94,76.48) | 65.41(63.10,67.73) | |
| 9 | Prepuberty | 636 | 103.77(102.96,104.58) | 104.58(103.67,105.48) | 100.46(98.72,102.19) | 62.77(62.11,63.42) | 63.15(62.42,63.88) | 61.21(59.75,62.67) |
| Puberty | 205 | 106.25(104.83,107.67) | 107.51(103.80,111.22) | 106.06(104.52,107.61) | 64.87(63.70,66.03) | 62.68(58.36,67.00) | 65.18(63.99,66.38) | |
| 10 | Prepuberty | 364 | 104.06(102.96,105.16) | 104.76(103.63,105.89) | 98.54(94.82,102.27) | 62.54(61.67,63.41) | 62.76(61.83,63.70) | 60.78(58.50,63.06) |
| Puberty | 410 | 107.53(106.41,108.65) | 110.02(107.92,112.11) | 106.57(105.25,107.89) | 65.64(64.73,66.55) | 65.68(63.78,67.59) | 65.62(64.58,66.66) | |
| 11 | Prepuberty | 135 | 104.46(102.72,106.20) | 105.28(103.50,107.07) | 95.18(89.99,100.38) | 62.05(60.28,63.82) | 62.19(60.29,64.09) | 60.45(55.99,64.91) |
| Puberty | 604 | 110.38(109.54,111.23) | 110.42(109.13,111.71) | 110.36(109.25,111.46) | 65.70(64.94,66.46) | 64.10(62.92,65.28) | 67.11(66.16,68.06) | |
| 12 | Prepuberty | 21 | 105.08(100.03,110.13) | 104.61(99.07,110.16) | 109.50(52.32,166.68) | 60.44(55.79,65.10) | 59.12(54.39,63.86) | 73.00(47.59,98.41) |
| Puberty | 516 | 112.44(111.51,113.37) | 113.24(111.91,114.56) | 111.57(110.27,112.87) | 65.44(64.59,66.29) | 63.87(62.61,65.13) | 67.15(66.05,68.25) | |
| Total | Prepuberty | 2300 | 102.47(102.03,102.91) | 104.01(103.50,104.52) | 98.20(97.39,99.02) | 61.81(61.44,62.18) | 62.38(61.94,62.81) | 60.23(59.58,60.89) |
| Puberty | 1846 | 109.65(109.15,110.16) | 111.33(110.50,112.15) | 108.63(108.00,109.26) | 65.51(65.07,65.94) | 64.25(63.49,65.02) | 66.28(65.76,66.79) | |
| Pubertal timing | Non‐early | 4022 | 105.57(105.21,105.92) | 106.04(105.58,106.49) | 104.92(104.36,105.48) | 63.41(63.12,63.69) | 62.87(62.48,63.25) | 64.15(63.71,64.58) |
| Early | 124 | 109.03(107.11,110.95) | 110.46(107.67,113.24) | 107.56(104.89,110.23) | 65.12(63.18,67.06) | 65.14(62.32,67.95) | 65.10(62.35,67.85) |
This table shows the mean and 95% CI of BP levels.
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure.
Indicated that the differences in blood pressure levels were statistically significant between the prepuberty and puberty groups or pubertal timing early group and non‐early groups (p < .05).
– indicates there is no data (because the number of boys entering puberty is zero in the 7‐year‐old group).
FIGURE 2The prevalence of elevated blood pressure at different pubertal developmental status in Chinese children aged 7–12 years. * p < .05
The relationship between different pubertal developmental status and BP levels in Chinese children aged 7–12 years
| Group | N | SBP (mmHg) | Boys’ SBP (mmHg) | Girls’ SBP (mmHg) | DBP (mmHg) | Boys’ DBP (mmHg) | Girls’ DBP (mmHg) | |
|---|---|---|---|---|---|---|---|---|
| Puberty onset | Prepuberty | 2300 | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) |
| Puberty | 1846 | 3.84(2.92,4.75) | 3.65(2.41,4.88) | 4.11(2.71,5.52) | 2.24(1.39,3.09) | 1.15(‐0.04,2.33) | 3.39(2.18,4.61) | |
| Pubertal timing | Non‐early | 4022 | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) |
| Early | 124 | 3.19(1.37,5.01) | 2.91(0.41,5.41) | 4.27(1.56,6.99) | 1.54(‐0.14,3.22) | 1.25(‐1.15,3.64) | 2.61(0.26,4.96) | |
| Pubertal stage | Stage I | 2300 | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) | 0 (reference) |
| Stage II | 863 | 3.09(2.14,4.04) | 2.39(1.08,3.70) | 3.80(2.37,5.22) | 2.05(1.17,2.93) | 1.36(0.09,2.63) | 3.10(1.87,4.34) | |
| Stage III | 594 | 6.02(4.80,7.24) | 5.53(3.83,7.23) | 6.13(4.27,7.99) | 2.74(1.61,3.88) | 0.07(‐1.58,1.72) | 4.64(3.04,6.25) | |
| Stage IV‐V | 389 | 7.22(5.72,8.71) | 9.70(7.19,12.21) | 6.11(3.86,8.35) | 3.75(2.36,5.14) | 3.04(0.60,5.47) | 3.75(1.81,5.70) | |
This table shows the coefficient and 95%CI of multiple linear regression.
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure.
Indicated that the differences in blood pressure levels were statistically significant compared with the reference (p < .05).
Adjusting for children's age, (sex), body mass index, taste preference, and family history of hypertension.
The association between different pubertal developmental status and EBP in Chinese children aged 7–12 years
| Group | EBP | Boys’ EBP | Girls’ EBP | ESBP | Boys’ ESBP | Girls’ ESBP | EDBP | Boys’ EDBP | Girls’ EDBP | |
|---|---|---|---|---|---|---|---|---|---|---|
| Puberty onset | Prepuberty | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| Puberty | 1.70(1.34,2.14) | 1.73(1.27,2.37) | 1.69(1.17,2.44) | 1.53(1.19,1.96) | 1.66(1.19,2.30) | 1.42(0.95,2.13) | 1.62(1.19,2.21) | 1.36(0.88,2.12) | 2.08(1.30,3.33) | |
| Pubertal timing | Non‐early | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| Early | 1.64(1.10,2.45) | 1.41(0.80,2.50) | 1.97(1.09,3.54) | 1.52(0.99,2.32) | 1.34(0.74,2.44) | 1.85(0.98,3.48) | 1.35(0.80,2.28) | 1.18(0.53,2.64) | 1.60(0.78,3.28) | |
| Pubertal stage | Stage I | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| Stage II | 1.57(1.23,2.01) | 1.46(1.04,2.06) | 1.65(1.13,2.40) | 1.41(1.08,1.84) | 1.37(0.95,1.96) | 1.38(0.91,2.10) | 1.52(1.10,2.10) | 1.31(0.82,2.09) | 1.91(1.17,3.11) | |
| Stage III | 2.32(1.70,3.17) | 2.34(1.52,3.61) | 2.23(1.38,3.59) | 2.09(1.50,2.92) | 2.27(1.44,3.57) | 1.76(1.04,2.96) | 2.15(1.42,3.25) | 1.41(0.76,2.61) | 3.07(1.67,5.63) | |
| Stage IV‐V | 2.82(1.94,4.10) | 4.21(2.34,7.58) | 2.39(1.36,4.21) | 2.65(1.79,3.94) | 5.04(2.76,9.20) | 1.83(0.99,3.38) | 2.10(1.27,3.46) | 2.10(0.92,4.80) | 2.43(1.17,5.05) |
This table shows the OR and 95%CI of multiple logistics regression.
Abbreviations: EBP, elevated blood pressure; EDBP, elevated diastolic blood pressure; ESBP, elevated systolic blood pressure.
Indicated that the odds of elevated blood pressure were statistically significant compared with the reference (p < .05).
Adjusting for children's age, (sex), body mass index, taste preference, and family history of hypertension.